» Articles » PMID: 16236241

Assaying Bcr-Abl Kinase Activity and Inhibition in Whole Cell Extracts by Phosphorylation of Substrates Immobilized on Agarose Beads

Overview
Journal Anal Biochem
Publisher Elsevier
Specialty Biochemistry
Date 2005 Oct 21
PMID 16236241
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

There is a current and increasing demand for simple, robust, nonradioactive assays of protein tyrosine kinase activity with applications for clinical diagnosis and high-throughput screening of potential molecularly targeted therapeutic agents. One significant challenge is to detect and measure the activity of specific kinases with key roles in cell signaling as an approach to distinguish normal cells from cancer cells and as a means of evaluating targeted drug efficacy and resistance in cancer cells. Here, we describe a method in which kinase substrates fused to glutathione-S-transferase and immobilized on glutathione agarose beads are phosphorylated, eluted, and then assayed to detect kinase activity. The activity of recombinant, purified c-Abl kinase or Bcr-Abl kinase in whole cell extracts can be detected with equivalent specificity, sensitivity, and reproducibility. Similarly, inhibition of recombinant c-Abl or Bcr-Abl in cells or cell extracts by imatinib mesylate and other Bcr-Abl targeted kinase inhibitors is readily assayed. This simple kinase assay is sufficiently straightforward and robust for use in clinical laboratories and is potentially adaptable to high-throughput assay formats.

Citing Articles

A multiple reaction monitoring (MRM) method to detect Bcr-Abl kinase activity in CML using a peptide biosensor.

Yang T, Eissler C, Hall M, Parker L PLoS One. 2013; 8(2):e56627.

PMID: 23437189 PMC: 3577862. DOI: 10.1371/journal.pone.0056627.


Photocleavable peptide-oligonucleotide conjugates for protein kinase assays by MALDI-TOF MS.

Zhou G, Khan F, Dai Q, Sylvester J, Kron S Mol Biosyst. 2012; 8(9):2395-404.

PMID: 22772337 PMC: 3462237. DOI: 10.1039/c2mb25163a.


A magnetic bead-based protein kinase assay with dual detection techniques.

Zhou G, Sylvester J, Wu D, Veach D, Kron S Anal Biochem. 2010; 408(1):5-11.

PMID: 20807497 PMC: 3034244. DOI: 10.1016/j.ab.2010.08.034.


Peptide reporters of kinase activity in whole cell lysates.

Wu D, Sylvester J, Parker L, Zhou G, Kron S Biopolymers. 2010; 94(4):475-86.

PMID: 20593469 PMC: 2914461. DOI: 10.1002/bip.21401.


A bead-based activity screen for small-molecule inhibitors of signal transduction in chronic myelogenous leukemia cells.

Sylvester J, Kron S Mol Cancer Ther. 2010; 9(5):1469-81.

PMID: 20423990 PMC: 2868067. DOI: 10.1158/1535-7163.MCT-10-0157.


References
1.
Shults M, Janes K, Lauffenburger D, Imperiali B . A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates. Nat Methods. 2005; 2(4):277-83. DOI: 10.1038/nmeth747. View

2.
Nagar B, Hantschel O, Young M, Scheffzek K, Veach D, Bornmann W . Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell. 2003; 112(6):859-71. DOI: 10.1016/s0092-8674(03)00194-6. View

3.
Deininger M . Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia. J Cancer Res Clin Oncol. 2003; 130(2):59-72. DOI: 10.1007/s00432-003-0502-2. View

4.
Sun X, Layton J, Elefanty A, Lieschke G . Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL--expressing cells, demonstrating synergy between AG490 and STI571. Blood. 2001; 97(7):2008-15. DOI: 10.1182/blood.v97.7.2008. View

5.
Heaney C, Kolibaba K, Bhat A, Oda T, Ohno S, Fanning S . Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation. Blood. 1997; 89(1):297-306. View